世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

世界および中国の人工臓器・医療用バイオニクス市場の洞察、2027年までの予測


Global and China Artificial Vital Organs and Medical Bionics Market Insights, Forecast to 2027

人工臓器とは、天然の臓器の代わりに、特定の機能や関連する機能を複製または増強して、患者ができるだけ早く通常の生活に戻れるようにする目的で、人体に移植または統合される装置のことであり、バイオニクスと... もっと見る

 

 

出版社 出版年月 電子版価格 言語
QYResearch
QYリサーチ
2021年10月14日 US$3,900
シングルユーザライセンス
ライセンス・価格情報・注文方法はこちら
英語

※当ページの内容はウェブ更新時の情報です。
最新版の価格やページ数などの情報についてはお問合せください。

日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


 

サマリー

人工臓器とは、天然の臓器の代わりに、特定の機能や関連する機能を複製または増強して、患者ができるだけ早く通常の生活に戻れるようにする目的で、人体に移植または統合される装置のことであり、バイオニクスとは、自然界に存在する生物学的手法やシステムを、工学システムや現代技術の研究や設計に応用することである。臓器移植を待つ患者の死亡率が上昇していることから、人工臓器の需要が高まっている。臓器移植を待つ患者と提供可能な臓器とのギャップが大きくなっていることから、人工臓器と医療用バイオニクスの市場は世界的に大きな成長を遂げています。

市場分析と洞察。世界および中国の人工臓器・医療用バイオニクス市場
本レポートでは、世界と中国の人工臓器・医療用バイオニクス市場に焦点を当てています。
2020年の人工臓器・医療用バイオニクスの世界市場規模はXX百万米ドルで、2021-2027年の間にXX%のCAGRで2027年末にはXX百万米ドルに達すると予想されています。中国では、人工バイタル臓器と医療用バイオニクスの市場規模は、2020年のXX百万米ドルから2027年にはXX百万米ドルまで、予測期間中にXX%のCAGRで成長すると予測されています。

世界の人工バイタル臓器・医療用バイオニクスの範囲と市場規模
Artificial Vital Organs and Medical Bionics市場は、地域(国)別、プレイヤー別、タイプ別、アプリケーション別に分類されています。世界のArtificial Vital Organs and Medical Bionics市場のプレーヤー、ステークホルダー、その他の参加者は、本レポートを強力なリソースとして活用することで、優位に立つことができるでしょう。セグメント別分析では、地域(国)別、タイプ別、アプリケーション別に、2016年から2027年までの収益と予測に焦点を当てています。
中国市場については、2016年から2027年の期間で、プレーヤー別、タイプ別、アプリケーション別の人工臓器と医療用バイオニクスの市場規模に焦点を当てています。主要プレイヤーには、中国で重要な役割を果たしているグローバルプレイヤーとローカルプレイヤーが含まれています。

タイプ別セグメント
人工バイタルオルガン
バイオニクス

用途別セグメント
病院
クリニック
その他

地域別
北アメリカ
米国
カナダ
ヨーロッパ
ドイツ
フランス
イギリス
イタリア
ロシア
アジアパシフィック
中国
日本
韓国
インド
オーストラリア
台湾
インドネシア
タイ
マレーシア
フィリピン
ベトナム
ラテンアメリカ
メキシコ
ブラジル
アルゼンチン
中近東・アフリカ
トルコ
サウジアラビア
U.A.E.

会社別
アボット
Abiomed, Inc.
旭化成メディカル株式会社
バクスター
サイバニクス・インク
エドワーズ
Ekso Bionics
ロシュ
フレゼニウス
バクスター・インターナショナル
イウォーク
ジャービックハート
メドトロニック
マイクロメッド・カーディオグラフィック
日機装
Ossur Hf
オットーボック
セカンドサイト・メディカル・プロダクツ社
シンカルディア・システムズ社
Thoratec Corporation
Touch Bionics, Inc.
Vital Therapies, Inc.
WorldHeart Corporation


ページTOPに戻る


目次

1 Study Coverage
1.1 Artificial Vital Organs and Medical Bionics Product Introduction
1.2 Market by Type
1.2.1 Global Artificial Vital Organs and Medical Bionics Market Size Growth Rate by Type
1.2.2 Artificial Vital Organs
1.2.3 Bionics
1.3 Market by Application
1.3.1 Global Artificial Vital Organs and Medical Bionics Market Size Growth Rate by Application
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary
2.1 Global Artificial Vital Organs and Medical Bionics Market Size, Estimates and Forecasts
2.1.1 Global Artificial Vital Organs and Medical Bionics Revenue 2016-2027
2.1.2 Global Artificial Vital Organs and Medical Bionics Sales 2016-2027
2.2 Global Artificial Vital Organs and Medical Bionics, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Artificial Vital Organs and Medical Bionics Historical Market Size by Region (2016-2021)
2.3.1 Global Artificial Vital Organs and Medical Bionics Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Artificial Vital Organs and Medical Bionics Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Artificial Vital Organs and Medical Bionics Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Artificial Vital Organs and Medical Bionics Sales Forecast by Region (2022-2027)
2.4.2 Global Artificial Vital Organs and Medical Bionics Revenue Forecast by Region (2022-2027)

3 Global Artificial Vital Organs and Medical Bionics Competitor Landscape by Players
3.1 Global Top Artificial Vital Organs and Medical Bionics Manufacturers by Sales
3.1.1 Global Artificial Vital Organs and Medical Bionics Sales by Manufacturer (2016-2021)
3.1.2 Global Artificial Vital Organs and Medical Bionics Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Artificial Vital Organs and Medical Bionics Manufacturers by Revenue
3.2.1 Key Artificial Vital Organs and Medical Bionics Manufacturers Covered: Ranking by Revenue
3.2.2 Global Artificial Vital Organs and Medical Bionics Revenue by Manufacturers (2016-2021)
3.2.3 Global Artificial Vital Organs and Medical Bionics Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Artificial Vital Organs and Medical Bionics Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Artificial Vital Organs and Medical Bionics Revenue in 2020
3.2.6 Global Artificial Vital Organs and Medical Bionics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Artificial Vital Organs and Medical Bionics Price by Manufacturers
3.4 Global Artificial Vital Organs and Medical Bionics Manufacturing Base Distribution, Product Types
3.4.1 Artificial Vital Organs and Medical Bionics Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Artificial Vital Organs and Medical Bionics Product Type
3.4.3 Date of International Manufacturers Enter into Artificial Vital Organs and Medical Bionics Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2016-2027)
4.1 Global Artificial Vital Organs and Medical Bionics Market Size by Type (2016-2021)
4.1.1 Global Artificial Vital Organs and Medical Bionics Sales by Type (2016-2021)
4.1.2 Global Artificial Vital Organs and Medical Bionics Revenue by Type (2016-2021)
4.1.3 Artificial Vital Organs and Medical Bionics Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Artificial Vital Organs and Medical Bionics Market Size Forecast by Type (2022-2027)
4.2.1 Global Artificial Vital Organs and Medical Bionics Sales Forecast by Type (2022-2027)
4.2.2 Global Artificial Vital Organs and Medical Bionics Revenue Forecast by Type (2022-2027)
4.2.3 Artificial Vital Organs and Medical Bionics Average Selling Price (ASP) Forecast by Type (2022-2027)

5 Breakdown Data by Application (2016-2027)
5.1 Global Artificial Vital Organs and Medical Bionics Market Size by Application (2016-2021)
5.1.1 Global Artificial Vital Organs and Medical Bionics Sales by Application (2016-2021)
5.1.2 Global Artificial Vital Organs and Medical Bionics Revenue by Application (2016-2021)
5.1.3 Artificial Vital Organs and Medical Bionics Price by Application (2016-2021)
5.2 Artificial Vital Organs and Medical Bionics Market Size Forecast by Application (2022-2027)
5.2.1 Global Artificial Vital Organs and Medical Bionics Sales Forecast by Application (2022-2027)
5.2.2 Global Artificial Vital Organs and Medical Bionics Revenue Forecast by Application (2022-2027)
5.2.3 Global Artificial Vital Organs and Medical Bionics Price Forecast by Application (2022-2027)

6 China by Players, Type and Application
6.1 China Artificial Vital Organs and Medical Bionics Market Size YoY Growth 2016-2027
6.1.1 China Artificial Vital Organs and Medical Bionics Sales YoY Growth 2016-2027
6.1.2 China Artificial Vital Organs and Medical Bionics Revenue YoY Growth 2016-2027
6.1.3 China Artificial Vital Organs and Medical Bionics Market Share in Global Market 2016-2027
6.2 China Artificial Vital Organs and Medical Bionics Market Size by Players (International and Local Players)
6.2.1 China Top Artificial Vital Organs and Medical Bionics Players by Sales (2016-2021)
6.2.2 China Top Artificial Vital Organs and Medical Bionics Players by Revenue (2016-2021)
6.3 China Artificial Vital Organs and Medical Bionics Historic Market Review by Type (2016-2021)
6.3.1 China Artificial Vital Organs and Medical Bionics Sales Market Share by Type (2016-2021)
6.3.2 China Artificial Vital Organs and Medical Bionics Revenue Market Share by Type (2016-2021)
6.3.3 China Artificial Vital Organs and Medical Bionics Price by Type (2016-2021)
6.4 China Artificial Vital Organs and Medical Bionics Market Estimates and Forecasts by Type (2022-2027)
6.4.1 China Artificial Vital Organs and Medical Bionics Sales Forecast by Type (2022-2027)
6.4.2 China Artificial Vital Organs and Medical Bionics Revenue Forecast by Type (2022-2027)
6.4.3 China Artificial Vital Organs and Medical Bionics Price Forecast by Type (2022-2027)
6.5 China Artificial Vital Organs and Medical Bionics Historic Market Review by Application (2016-2021)
6.5.1 China Artificial Vital Organs and Medical Bionics Sales Market Share by Application (2016-2021)
6.5.2 China Artificial Vital Organs and Medical Bionics Revenue Market Share by Application (2016-2021)
6.5.3 China Artificial Vital Organs and Medical Bionics Price by Application (2016-2021)
6.6 China Artificial Vital Organs and Medical Bionics Market Estimates and Forecasts by Application (2022-2027)
6.6.1 China Artificial Vital Organs and Medical Bionics Sales Forecast by Application (2022-2027)
6.6.2 China Artificial Vital Organs and Medical Bionics Revenue Forecast by Application (2022-2027)
6.6.3 China Artificial Vital Organs and Medical Bionics Price Forecast by Application (2022-2027)

7 North America
7.1 North America Artificial Vital Organs and Medical Bionics Market Size YoY Growth 2016-2027
7.2 North America Artificial Vital Organs and Medical Bionics Market Facts & Figures by Country
7.2.1 North America Artificial Vital Organs and Medical Bionics Sales by Country (2016-2021)
7.2.2 North America Artificial Vital Organs and Medical Bionics Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada

8 Asia Pacific
8.1 Asia Pacific Artificial Vital Organs and Medical Bionics Market Size YoY Growth 2016-2027
8.2 Asia Pacific Artificial Vital Organs and Medical Bionics Market Facts & Figures by Region
8.2.1 Asia Pacific Artificial Vital Organs and Medical Bionics Sales by Region (2016-2021)
8.2.2 Asia Pacific Artificial Vital Organs and Medical Bionics Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam

9 Europe
9.1 Europe Artificial Vital Organs and Medical Bionics Market Size YoY Growth 2016-2027
9.2 Europe Artificial Vital Organs and Medical Bionics Market Facts & Figures by Country
9.2.1 Europe Artificial Vital Organs and Medical Bionics Sales by Country (2016-2021)
9.2.2 Europe Artificial Vital Organs and Medical Bionics Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy

10 Latin America
10.1 Latin America Artificial Vital Organs and Medical Bionics Market Size YoY Growth 2016-2027
10.2 Latin America Artificial Vital Organs and Medical Bionics Market Facts & Figures by Country
10.2.1 Latin America Artificial Vital Organs and Medical Bionics Sales by Country (2016-2021)
10.2.2 Latin America Artificial Vital Organs and Medical Bionics Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina

11 Middle East and Africa
11.1 Middle East and Africa Artificial Vital Organs and Medical Bionics Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Artificial Vital Organs and Medical Bionics Market Facts & Figures by Country
11.2.1 Middle East and Africa Artificial Vital Organs and Medical Bionics Sales by Country (2016-2021)
11.2.2 Middle East and Africa Artificial Vital Organs and Medical Bionics Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E

12 Company Profiles
12.1 Abbott
12.1.1 Abbott Corporation Information
12.1.2 Abbott Description and Business Overview
12.1.3 Abbott Artificial Vital Organs and Medical Bionics Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Abbott Artificial Vital Organs and Medical Bionics Products Offered
12.1.5 Abbott Recent Development
12.2 Abiomed, Inc.
12.2.1 Abiomed, Inc. Corporation Information
12.2.2 Abiomed, Inc. Description and Business Overview
12.2.3 Abiomed, Inc. Artificial Vital Organs and Medical Bionics Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Abiomed, Inc. Artificial Vital Organs and Medical Bionics Products Offered
12.2.5 Abiomed, Inc. Recent Development
12.3 Asahi Kasei Medical Co., Ltd.
12.3.1 Asahi Kasei Medical Co., Ltd. Corporation Information
12.3.2 Asahi Kasei Medical Co., Ltd. Description and Business Overview
12.3.3 Asahi Kasei Medical Co., Ltd. Artificial Vital Organs and Medical Bionics Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Asahi Kasei Medical Co., Ltd. Artificial Vital Organs and Medical Bionics Products Offered
12.3.5 Asahi Kasei Medical Co., Ltd. Recent Development
12.4 Baxter
12.4.1 Baxter Corporation Information
12.4.2 Baxter Description and Business Overview
12.4.3 Baxter Artificial Vital Organs and Medical Bionics Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Baxter Artificial Vital Organs and Medical Bionics Products Offered
12.4.5 Baxter Recent Development
12.5 Cyberonics, Inc.
12.5.1 Cyberonics, Inc. Corporation Information
12.5.2 Cyberonics, Inc. Description and Business Overview
12.5.3 Cyberonics, Inc. Artificial Vital Organs and Medical Bionics Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Cyberonics, Inc. Artificial Vital Organs and Medical Bionics Products Offered
12.5.5 Cyberonics, Inc. Recent Development
12.6 Edwards
12.6.1 Edwards Corporation Information
12.6.2 Edwards Description and Business Overview
12.6.3 Edwards Artificial Vital Organs and Medical Bionics Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Edwards Artificial Vital Organs and Medical Bionics Products Offered
12.6.5 Edwards Recent Development
12.7 Ekso Bionics
12.7.1 Ekso Bionics Corporation Information
12.7.2 Ekso Bionics Description and Business Overview
12.7.3 Ekso Bionics Artificial Vital Organs and Medical Bionics Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Ekso Bionics Artificial Vital Organs and Medical Bionics Products Offered
12.7.5 Ekso Bionics Recent Development
12.8 Roche
12.8.1 Roche Corporation Information
12.8.2 Roche Description and Business Overview
12.8.3 Roche Artificial Vital Organs and Medical Bionics Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Roche Artificial Vital Organs and Medical Bionics Products Offered
12.8.5 Roche Recent Development
12.9 Fresenius
12.9.1 Fresenius Corporation Information
12.9.2 Fresenius Description and Business Overview
12.9.3 Fresenius Artificial Vital Organs and Medical Bionics Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Fresenius Artificial Vital Organs and Medical Bionics Products Offered
12.9.5 Fresenius Recent Development
12.10 Baxter International
12.10.1 Baxter International Corporation Information
12.10.2 Baxter International Description and Business Overview
12.10.3 Baxter International Artificial Vital Organs and Medical Bionics Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Baxter International Artificial Vital Organs and Medical Bionics Products Offered
12.10.5 Baxter International Recent Development
12.11 Abbott
12.11.1 Abbott Corporation Information
12.11.2 Abbott Description and Business Overview
12.11.3 Abbott Artificial Vital Organs and Medical Bionics Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Abbott Artificial Vital Organs and Medical Bionics Products Offered
12.11.5 Abbott Recent Development
12.12 Jarvik Heart
12.12.1 Jarvik Heart Corporation Information
12.12.2 Jarvik Heart Description and Business Overview
12.12.3 Jarvik Heart Artificial Vital Organs and Medical Bionics Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Jarvik Heart Products Offered
12.12.5 Jarvik Heart Recent Development
12.13 Medtronic
12.13.1 Medtronic Corporation Information
12.13.2 Medtronic Description and Business Overview
12.13.3 Medtronic Artificial Vital Organs and Medical Bionics Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Medtronic Products Offered
12.13.5 Medtronic Recent Development
12.14 Micromed Cardiovascular
12.14.1 Micromed Cardiovascular Corporation Information
12.14.2 Micromed Cardiovascular Description and Business Overview
12.14.3 Micromed Cardiovascular Artificial Vital Organs and Medical Bionics Sales, Revenue and Gross Margin (2016-2021)
12.14.4 Micromed Cardiovascular Products Offered
12.14.5 Micromed Cardiovascular Recent Development
12.15 Nikkiso
12.15.1 Nikkiso Corporation Information
12.15.2 Nikkiso Description and Business Overview
12.15.3 Nikkiso Artificial Vital Organs and Medical Bionics Sales, Revenue and Gross Margin (2016-2021)
12.15.4 Nikkiso Products Offered
12.15.5 Nikkiso Recent Development
12.16 Ossur Hf
12.16.1 Ossur Hf Corporation Information
12.16.2 Ossur Hf Description and Business Overview
12.16.3 Ossur Hf Artificial Vital Organs and Medical Bionics Sales, Revenue and Gross Margin (2016-2021)
12.16.4 Ossur Hf Products Offered
12.16.5 Ossur Hf Recent Development
12.17 Ottobock
12.17.1 Ottobock Corporation Information
12.17.2 Ottobock Description and Business Overview
12.17.3 Ottobock Artificial Vital Organs and Medical Bionics Sales, Revenue and Gross Margin (2016-2021)
12.17.4 Ottobock Products Offered
12.17.5 Ottobock Recent Development
12.18 Second Sight Medical Products, Inc.
12.18.1 Second Sight Medical Products, Inc. Corporation Information
12.18.2 Second Sight Medical Products, Inc. Description and Business Overview
12.18.3 Second Sight Medical Products, Inc. Artificial Vital Organs and Medical Bionics Sales, Revenue and Gross Margin (2016-2021)
12.18.4 Second Sight Medical Products, Inc. Products Offered
12.18.5 Second Sight Medical Products, Inc. Recent Development
12.19 Syncardia Systems, Inc.
12.19.1 Syncardia Systems, Inc. Corporation Information
12.19.2 Syncardia Systems, Inc. Description and Business Overview
12.19.3 Syncardia Systems, Inc. Artificial Vital Organs and Medical Bionics Sales, Revenue and Gross Margin (2016-2021)
12.19.4 Syncardia Systems, Inc. Products Offered
12.19.5 Syncardia Systems, Inc. Recent Development
12.20 Thoratec Corporation
12.20.1 Thoratec Corporation Corporation Information
12.20.2 Thoratec Corporation Description and Business Overview
12.20.3 Thoratec Corporation Artificial Vital Organs and Medical Bionics Sales, Revenue and Gross Margin (2016-2021)
12.20.4 Thoratec Corporation Products Offered
12.20.5 Thoratec Corporation Recent Development
12.21 Touch Bionics, Inc.
12.21.1 Touch Bionics, Inc. Corporation Information
12.21.2 Touch Bionics, Inc. Description and Business Overview
12.21.3 Touch Bionics, Inc. Artificial Vital Organs and Medical Bionics Sales, Revenue and Gross Margin (2016-2021)
12.21.4 Touch Bionics, Inc. Products Offered
12.21.5 Touch Bionics, Inc. Recent Development
12.22 Vital Therapies, Inc.
12.22.1 Vital Therapies, Inc. Corporation Information
12.22.2 Vital Therapies, Inc. Description and Business Overview
12.22.3 Vital Therapies, Inc. Artificial Vital Organs and Medical Bionics Sales, Revenue and Gross Margin (2016-2021)
12.22.4 Vital Therapies, Inc. Products Offered
12.22.5 Vital Therapies, Inc. Recent Development
12.23 WorldHeart Corporation
12.23.1 WorldHeart Corporation Corporation Information
12.23.2 WorldHeart Corporation Description and Business Overview
12.23.3 WorldHeart Corporation Artificial Vital Organs and Medical Bionics Sales, Revenue and Gross Margin (2016-2021)
12.23.4 WorldHeart Corporation Products Offered
12.23.5 WorldHeart Corporation Recent Development

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Artificial Vital Organs and Medical Bionics Industry Trends
13.2 Artificial Vital Organs and Medical Bionics Market Drivers
13.3 Artificial Vital Organs and Medical Bionics Market Challenges
13.4 Artificial Vital Organs and Medical Bionics Market Restraints

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Artificial Vital Organs and Medical Bionics Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

 

ページTOPに戻る


 

Summary

The artificial organs are devices implanted or integrated into a human body in order to replace a natural organ, for the purpose of duplicating or augmenting a specific function or a group of related functions for the patient to return to a normal life as soon as possible, whereas bionics is the application of biological methods and systems found in nature to the study and design of engineering systems and modern technology. The increasing mortality rate of patients awaiting organ transplant has intensified the demand for artificial organs. The artificial vital organs and medical bionics market is undergoing impressive growth across the globe due to increase in the gap between patients awaiting organ transplant and the availability of donor organs.

Market Analysis and Insights: Global and China Artificial Vital Organs and Medical Bionics Market
This report focuses on global and China Artificial Vital Organs and Medical Bionics market.
In 2020, the global Artificial Vital Organs and Medical Bionics market size was US$ XX million and it is expected to reach US$ XX million by the end of 2027, with a CAGR of XX% during 2021-2027. In China the Artificial Vital Organs and Medical Bionics market size is expected to grow from US$ XX million in 2020 to US$ XX million by 2027, at a CAGR of XX% during the forecast period.

Global Artificial Vital Organs and Medical Bionics Scope and Market Size
Artificial Vital Organs and Medical Bionics market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Artificial Vital Organs and Medical Bionics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.
For China market, this report focuses on the Artificial Vital Organs and Medical Bionics market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in China.

Segment by Type
Artificial Vital Organs
Bionics

Segment by Application
Hospitals
Clinics
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E

By Company
Abbott
Abiomed, Inc.
Asahi Kasei Medical Co., Ltd.
Baxter
Cyberonics, Inc.
Edwards
Ekso Bionics
Roche
Fresenius
Baxter International
Iwalk
Jarvik Heart
Medtronic
Micromed Cardiovascular
Nikkiso
Ossur Hf
Ottobock
Second Sight Medical Products, Inc.
Syncardia Systems, Inc.
Thoratec Corporation
Touch Bionics, Inc.
Vital Therapies, Inc.
WorldHeart Corporation



ページTOPに戻る


Table of Contents

1 Study Coverage
1.1 Artificial Vital Organs and Medical Bionics Product Introduction
1.2 Market by Type
1.2.1 Global Artificial Vital Organs and Medical Bionics Market Size Growth Rate by Type
1.2.2 Artificial Vital Organs
1.2.3 Bionics
1.3 Market by Application
1.3.1 Global Artificial Vital Organs and Medical Bionics Market Size Growth Rate by Application
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary
2.1 Global Artificial Vital Organs and Medical Bionics Market Size, Estimates and Forecasts
2.1.1 Global Artificial Vital Organs and Medical Bionics Revenue 2016-2027
2.1.2 Global Artificial Vital Organs and Medical Bionics Sales 2016-2027
2.2 Global Artificial Vital Organs and Medical Bionics, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Artificial Vital Organs and Medical Bionics Historical Market Size by Region (2016-2021)
2.3.1 Global Artificial Vital Organs and Medical Bionics Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Artificial Vital Organs and Medical Bionics Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Artificial Vital Organs and Medical Bionics Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Artificial Vital Organs and Medical Bionics Sales Forecast by Region (2022-2027)
2.4.2 Global Artificial Vital Organs and Medical Bionics Revenue Forecast by Region (2022-2027)

3 Global Artificial Vital Organs and Medical Bionics Competitor Landscape by Players
3.1 Global Top Artificial Vital Organs and Medical Bionics Manufacturers by Sales
3.1.1 Global Artificial Vital Organs and Medical Bionics Sales by Manufacturer (2016-2021)
3.1.2 Global Artificial Vital Organs and Medical Bionics Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Artificial Vital Organs and Medical Bionics Manufacturers by Revenue
3.2.1 Key Artificial Vital Organs and Medical Bionics Manufacturers Covered: Ranking by Revenue
3.2.2 Global Artificial Vital Organs and Medical Bionics Revenue by Manufacturers (2016-2021)
3.2.3 Global Artificial Vital Organs and Medical Bionics Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Artificial Vital Organs and Medical Bionics Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Artificial Vital Organs and Medical Bionics Revenue in 2020
3.2.6 Global Artificial Vital Organs and Medical Bionics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Artificial Vital Organs and Medical Bionics Price by Manufacturers
3.4 Global Artificial Vital Organs and Medical Bionics Manufacturing Base Distribution, Product Types
3.4.1 Artificial Vital Organs and Medical Bionics Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Artificial Vital Organs and Medical Bionics Product Type
3.4.3 Date of International Manufacturers Enter into Artificial Vital Organs and Medical Bionics Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2016-2027)
4.1 Global Artificial Vital Organs and Medical Bionics Market Size by Type (2016-2021)
4.1.1 Global Artificial Vital Organs and Medical Bionics Sales by Type (2016-2021)
4.1.2 Global Artificial Vital Organs and Medical Bionics Revenue by Type (2016-2021)
4.1.3 Artificial Vital Organs and Medical Bionics Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Artificial Vital Organs and Medical Bionics Market Size Forecast by Type (2022-2027)
4.2.1 Global Artificial Vital Organs and Medical Bionics Sales Forecast by Type (2022-2027)
4.2.2 Global Artificial Vital Organs and Medical Bionics Revenue Forecast by Type (2022-2027)
4.2.3 Artificial Vital Organs and Medical Bionics Average Selling Price (ASP) Forecast by Type (2022-2027)

5 Breakdown Data by Application (2016-2027)
5.1 Global Artificial Vital Organs and Medical Bionics Market Size by Application (2016-2021)
5.1.1 Global Artificial Vital Organs and Medical Bionics Sales by Application (2016-2021)
5.1.2 Global Artificial Vital Organs and Medical Bionics Revenue by Application (2016-2021)
5.1.3 Artificial Vital Organs and Medical Bionics Price by Application (2016-2021)
5.2 Artificial Vital Organs and Medical Bionics Market Size Forecast by Application (2022-2027)
5.2.1 Global Artificial Vital Organs and Medical Bionics Sales Forecast by Application (2022-2027)
5.2.2 Global Artificial Vital Organs and Medical Bionics Revenue Forecast by Application (2022-2027)
5.2.3 Global Artificial Vital Organs and Medical Bionics Price Forecast by Application (2022-2027)

6 China by Players, Type and Application
6.1 China Artificial Vital Organs and Medical Bionics Market Size YoY Growth 2016-2027
6.1.1 China Artificial Vital Organs and Medical Bionics Sales YoY Growth 2016-2027
6.1.2 China Artificial Vital Organs and Medical Bionics Revenue YoY Growth 2016-2027
6.1.3 China Artificial Vital Organs and Medical Bionics Market Share in Global Market 2016-2027
6.2 China Artificial Vital Organs and Medical Bionics Market Size by Players (International and Local Players)
6.2.1 China Top Artificial Vital Organs and Medical Bionics Players by Sales (2016-2021)
6.2.2 China Top Artificial Vital Organs and Medical Bionics Players by Revenue (2016-2021)
6.3 China Artificial Vital Organs and Medical Bionics Historic Market Review by Type (2016-2021)
6.3.1 China Artificial Vital Organs and Medical Bionics Sales Market Share by Type (2016-2021)
6.3.2 China Artificial Vital Organs and Medical Bionics Revenue Market Share by Type (2016-2021)
6.3.3 China Artificial Vital Organs and Medical Bionics Price by Type (2016-2021)
6.4 China Artificial Vital Organs and Medical Bionics Market Estimates and Forecasts by Type (2022-2027)
6.4.1 China Artificial Vital Organs and Medical Bionics Sales Forecast by Type (2022-2027)
6.4.2 China Artificial Vital Organs and Medical Bionics Revenue Forecast by Type (2022-2027)
6.4.3 China Artificial Vital Organs and Medical Bionics Price Forecast by Type (2022-2027)
6.5 China Artificial Vital Organs and Medical Bionics Historic Market Review by Application (2016-2021)
6.5.1 China Artificial Vital Organs and Medical Bionics Sales Market Share by Application (2016-2021)
6.5.2 China Artificial Vital Organs and Medical Bionics Revenue Market Share by Application (2016-2021)
6.5.3 China Artificial Vital Organs and Medical Bionics Price by Application (2016-2021)
6.6 China Artificial Vital Organs and Medical Bionics Market Estimates and Forecasts by Application (2022-2027)
6.6.1 China Artificial Vital Organs and Medical Bionics Sales Forecast by Application (2022-2027)
6.6.2 China Artificial Vital Organs and Medical Bionics Revenue Forecast by Application (2022-2027)
6.6.3 China Artificial Vital Organs and Medical Bionics Price Forecast by Application (2022-2027)

7 North America
7.1 North America Artificial Vital Organs and Medical Bionics Market Size YoY Growth 2016-2027
7.2 North America Artificial Vital Organs and Medical Bionics Market Facts & Figures by Country
7.2.1 North America Artificial Vital Organs and Medical Bionics Sales by Country (2016-2021)
7.2.2 North America Artificial Vital Organs and Medical Bionics Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada

8 Asia Pacific
8.1 Asia Pacific Artificial Vital Organs and Medical Bionics Market Size YoY Growth 2016-2027
8.2 Asia Pacific Artificial Vital Organs and Medical Bionics Market Facts & Figures by Region
8.2.1 Asia Pacific Artificial Vital Organs and Medical Bionics Sales by Region (2016-2021)
8.2.2 Asia Pacific Artificial Vital Organs and Medical Bionics Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam

9 Europe
9.1 Europe Artificial Vital Organs and Medical Bionics Market Size YoY Growth 2016-2027
9.2 Europe Artificial Vital Organs and Medical Bionics Market Facts & Figures by Country
9.2.1 Europe Artificial Vital Organs and Medical Bionics Sales by Country (2016-2021)
9.2.2 Europe Artificial Vital Organs and Medical Bionics Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy

10 Latin America
10.1 Latin America Artificial Vital Organs and Medical Bionics Market Size YoY Growth 2016-2027
10.2 Latin America Artificial Vital Organs and Medical Bionics Market Facts & Figures by Country
10.2.1 Latin America Artificial Vital Organs and Medical Bionics Sales by Country (2016-2021)
10.2.2 Latin America Artificial Vital Organs and Medical Bionics Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina

11 Middle East and Africa
11.1 Middle East and Africa Artificial Vital Organs and Medical Bionics Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Artificial Vital Organs and Medical Bionics Market Facts & Figures by Country
11.2.1 Middle East and Africa Artificial Vital Organs and Medical Bionics Sales by Country (2016-2021)
11.2.2 Middle East and Africa Artificial Vital Organs and Medical Bionics Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E

12 Company Profiles
12.1 Abbott
12.1.1 Abbott Corporation Information
12.1.2 Abbott Description and Business Overview
12.1.3 Abbott Artificial Vital Organs and Medical Bionics Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Abbott Artificial Vital Organs and Medical Bionics Products Offered
12.1.5 Abbott Recent Development
12.2 Abiomed, Inc.
12.2.1 Abiomed, Inc. Corporation Information
12.2.2 Abiomed, Inc. Description and Business Overview
12.2.3 Abiomed, Inc. Artificial Vital Organs and Medical Bionics Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Abiomed, Inc. Artificial Vital Organs and Medical Bionics Products Offered
12.2.5 Abiomed, Inc. Recent Development
12.3 Asahi Kasei Medical Co., Ltd.
12.3.1 Asahi Kasei Medical Co., Ltd. Corporation Information
12.3.2 Asahi Kasei Medical Co., Ltd. Description and Business Overview
12.3.3 Asahi Kasei Medical Co., Ltd. Artificial Vital Organs and Medical Bionics Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Asahi Kasei Medical Co., Ltd. Artificial Vital Organs and Medical Bionics Products Offered
12.3.5 Asahi Kasei Medical Co., Ltd. Recent Development
12.4 Baxter
12.4.1 Baxter Corporation Information
12.4.2 Baxter Description and Business Overview
12.4.3 Baxter Artificial Vital Organs and Medical Bionics Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Baxter Artificial Vital Organs and Medical Bionics Products Offered
12.4.5 Baxter Recent Development
12.5 Cyberonics, Inc.
12.5.1 Cyberonics, Inc. Corporation Information
12.5.2 Cyberonics, Inc. Description and Business Overview
12.5.3 Cyberonics, Inc. Artificial Vital Organs and Medical Bionics Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Cyberonics, Inc. Artificial Vital Organs and Medical Bionics Products Offered
12.5.5 Cyberonics, Inc. Recent Development
12.6 Edwards
12.6.1 Edwards Corporation Information
12.6.2 Edwards Description and Business Overview
12.6.3 Edwards Artificial Vital Organs and Medical Bionics Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Edwards Artificial Vital Organs and Medical Bionics Products Offered
12.6.5 Edwards Recent Development
12.7 Ekso Bionics
12.7.1 Ekso Bionics Corporation Information
12.7.2 Ekso Bionics Description and Business Overview
12.7.3 Ekso Bionics Artificial Vital Organs and Medical Bionics Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Ekso Bionics Artificial Vital Organs and Medical Bionics Products Offered
12.7.5 Ekso Bionics Recent Development
12.8 Roche
12.8.1 Roche Corporation Information
12.8.2 Roche Description and Business Overview
12.8.3 Roche Artificial Vital Organs and Medical Bionics Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Roche Artificial Vital Organs and Medical Bionics Products Offered
12.8.5 Roche Recent Development
12.9 Fresenius
12.9.1 Fresenius Corporation Information
12.9.2 Fresenius Description and Business Overview
12.9.3 Fresenius Artificial Vital Organs and Medical Bionics Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Fresenius Artificial Vital Organs and Medical Bionics Products Offered
12.9.5 Fresenius Recent Development
12.10 Baxter International
12.10.1 Baxter International Corporation Information
12.10.2 Baxter International Description and Business Overview
12.10.3 Baxter International Artificial Vital Organs and Medical Bionics Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Baxter International Artificial Vital Organs and Medical Bionics Products Offered
12.10.5 Baxter International Recent Development
12.11 Abbott
12.11.1 Abbott Corporation Information
12.11.2 Abbott Description and Business Overview
12.11.3 Abbott Artificial Vital Organs and Medical Bionics Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Abbott Artificial Vital Organs and Medical Bionics Products Offered
12.11.5 Abbott Recent Development
12.12 Jarvik Heart
12.12.1 Jarvik Heart Corporation Information
12.12.2 Jarvik Heart Description and Business Overview
12.12.3 Jarvik Heart Artificial Vital Organs and Medical Bionics Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Jarvik Heart Products Offered
12.12.5 Jarvik Heart Recent Development
12.13 Medtronic
12.13.1 Medtronic Corporation Information
12.13.2 Medtronic Description and Business Overview
12.13.3 Medtronic Artificial Vital Organs and Medical Bionics Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Medtronic Products Offered
12.13.5 Medtronic Recent Development
12.14 Micromed Cardiovascular
12.14.1 Micromed Cardiovascular Corporation Information
12.14.2 Micromed Cardiovascular Description and Business Overview
12.14.3 Micromed Cardiovascular Artificial Vital Organs and Medical Bionics Sales, Revenue and Gross Margin (2016-2021)
12.14.4 Micromed Cardiovascular Products Offered
12.14.5 Micromed Cardiovascular Recent Development
12.15 Nikkiso
12.15.1 Nikkiso Corporation Information
12.15.2 Nikkiso Description and Business Overview
12.15.3 Nikkiso Artificial Vital Organs and Medical Bionics Sales, Revenue and Gross Margin (2016-2021)
12.15.4 Nikkiso Products Offered
12.15.5 Nikkiso Recent Development
12.16 Ossur Hf
12.16.1 Ossur Hf Corporation Information
12.16.2 Ossur Hf Description and Business Overview
12.16.3 Ossur Hf Artificial Vital Organs and Medical Bionics Sales, Revenue and Gross Margin (2016-2021)
12.16.4 Ossur Hf Products Offered
12.16.5 Ossur Hf Recent Development
12.17 Ottobock
12.17.1 Ottobock Corporation Information
12.17.2 Ottobock Description and Business Overview
12.17.3 Ottobock Artificial Vital Organs and Medical Bionics Sales, Revenue and Gross Margin (2016-2021)
12.17.4 Ottobock Products Offered
12.17.5 Ottobock Recent Development
12.18 Second Sight Medical Products, Inc.
12.18.1 Second Sight Medical Products, Inc. Corporation Information
12.18.2 Second Sight Medical Products, Inc. Description and Business Overview
12.18.3 Second Sight Medical Products, Inc. Artificial Vital Organs and Medical Bionics Sales, Revenue and Gross Margin (2016-2021)
12.18.4 Second Sight Medical Products, Inc. Products Offered
12.18.5 Second Sight Medical Products, Inc. Recent Development
12.19 Syncardia Systems, Inc.
12.19.1 Syncardia Systems, Inc. Corporation Information
12.19.2 Syncardia Systems, Inc. Description and Business Overview
12.19.3 Syncardia Systems, Inc. Artificial Vital Organs and Medical Bionics Sales, Revenue and Gross Margin (2016-2021)
12.19.4 Syncardia Systems, Inc. Products Offered
12.19.5 Syncardia Systems, Inc. Recent Development
12.20 Thoratec Corporation
12.20.1 Thoratec Corporation Corporation Information
12.20.2 Thoratec Corporation Description and Business Overview
12.20.3 Thoratec Corporation Artificial Vital Organs and Medical Bionics Sales, Revenue and Gross Margin (2016-2021)
12.20.4 Thoratec Corporation Products Offered
12.20.5 Thoratec Corporation Recent Development
12.21 Touch Bionics, Inc.
12.21.1 Touch Bionics, Inc. Corporation Information
12.21.2 Touch Bionics, Inc. Description and Business Overview
12.21.3 Touch Bionics, Inc. Artificial Vital Organs and Medical Bionics Sales, Revenue and Gross Margin (2016-2021)
12.21.4 Touch Bionics, Inc. Products Offered
12.21.5 Touch Bionics, Inc. Recent Development
12.22 Vital Therapies, Inc.
12.22.1 Vital Therapies, Inc. Corporation Information
12.22.2 Vital Therapies, Inc. Description and Business Overview
12.22.3 Vital Therapies, Inc. Artificial Vital Organs and Medical Bionics Sales, Revenue and Gross Margin (2016-2021)
12.22.4 Vital Therapies, Inc. Products Offered
12.22.5 Vital Therapies, Inc. Recent Development
12.23 WorldHeart Corporation
12.23.1 WorldHeart Corporation Corporation Information
12.23.2 WorldHeart Corporation Description and Business Overview
12.23.3 WorldHeart Corporation Artificial Vital Organs and Medical Bionics Sales, Revenue and Gross Margin (2016-2021)
12.23.4 WorldHeart Corporation Products Offered
12.23.5 WorldHeart Corporation Recent Development

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Artificial Vital Organs and Medical Bionics Industry Trends
13.2 Artificial Vital Organs and Medical Bionics Market Drivers
13.3 Artificial Vital Organs and Medical Bionics Market Challenges
13.4 Artificial Vital Organs and Medical Bionics Market Restraints

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Artificial Vital Organs and Medical Bionics Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります


よくあるご質問


QYResearch社はどのような調査会社ですか?


QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。   QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/09/19 10:28

144.64 円

160.77 円

193.27 円

ページTOPに戻る